Harnessing semen-derived exosomes for noninvasive fundus drug delivery

Chinese scientists publish a study showing that tiny natural bubbles (exosomes) extracted from pig semen can be turned into safe eye drops. These exosomes temporarily loosen the tight barriers in the eye (like the cornea and blood-retinal barrier) thanks to a protein called EGF on their surface.

This allows a loaded anti-cancer nanozyme drug to reach the back of the eye (retina) far better than regular drops. In mouse models of retinoblastoma (a rare childhood eye cancer), the eye drops dramatically shrank tumors—to just ~2.35% of the size in untreated mice—while preserving vision, causing minimal toxicity or immune reaction, and working through multiple cell-killing pathways (oxidative stress, ferroptosis, and apoptosis).

The researchers highlight this as a promising non-invasive platform not just for eye diseases but potentially for crossing similar barriers elsewhere in the body, such as the blood-brain barrier for Alzheimer's treatments. It's still preclinical (cells and animals only), with no human trials yet, but the approach uses abundant, human-compatible pig material for better biocompatibility and scalability.

You can read the published study here.